Stock Alert: Novavax Jumps Nearly 15% As Coronavirus Vaccine Trials Begins

Shares of Novavax Inc. (NVAX) are gaining nearly 15% on Tuesday morning after the biotech company announced it has initiated a trial on its coronavirus vaccine candidate.